Tags

Type your tag names separated by a space and hit enter

Lipid management in chronic kidney disease, hemodialysis, and transplantation.
Endocrinol Metab Clin North Am. 2009 Mar; 38(1):223-34.EM

Abstract

Recent studies have shown the spectrum of dyslipidemia in patients who have chronic kidney disease (CKD) or end-stage renal disease to be different from that of the general population. This article discusses the pathophysiology of dyslipidemia in CKD, dialysis, and renal transplant patients, the therapeutic options, and their association with clinical outcomes. Whenever possible, comparisons are made to outcomes in the general population.

Links

Publisher Full Text (DOI)

Authors+Show Affiliations

Montague T
Division of Kidney Disease and Hypertension, 593 Eddy Street, APC 9, Brown Medical School, Providence, RI 02903, USA. tmontague@lifespan.org
Murphy B
No affiliation info available

MeSH

Cardiovascular DiseasesChronic DiseaseDyslipidemiasGuidelines as TopicHumansHydroxymethylglutaryl-CoA Reductase InhibitorsHypolipidemic AgentsKidney DiseasesKidney TransplantationRenal Dialysis

Pub Type(s)

Journal Article
Review

Language

eng

PubMed ID

19217521

Citation

Montague, Terri, and Barbara Murphy. "Lipid Management in Chronic Kidney Disease, Hemodialysis, and Transplantation." Endocrinology and Metabolism Clinics of North America, vol. 38, no. 1, 2009, pp. 223-34.
Montague T, Murphy B. Lipid management in chronic kidney disease, hemodialysis, and transplantation. Endocrinol Metab Clin North Am. 2009;38(1):223-34.
Montague, T., & Murphy, B. (2009). Lipid management in chronic kidney disease, hemodialysis, and transplantation. Endocrinology and Metabolism Clinics of North America, 38(1), 223-34. https://doi.org/10.1016/j.ecl.2008.11.004
Montague T, Murphy B. Lipid Management in Chronic Kidney Disease, Hemodialysis, and Transplantation. Endocrinol Metab Clin North Am. 2009;38(1):223-34. PubMed PMID: 19217521.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Lipid management in chronic kidney disease, hemodialysis, and transplantation. AU - Montague,Terri, AU - Murphy,Barbara, PY - 2009/2/17/entrez PY - 2009/2/17/pubmed PY - 2009/5/12/medline SP - 223 EP - 34 JF - Endocrinology and metabolism clinics of North America JO - Endocrinol Metab Clin North Am VL - 38 IS - 1 N2 - Recent studies have shown the spectrum of dyslipidemia in patients who have chronic kidney disease (CKD) or end-stage renal disease to be different from that of the general population. This article discusses the pathophysiology of dyslipidemia in CKD, dialysis, and renal transplant patients, the therapeutic options, and their association with clinical outcomes. Whenever possible, comparisons are made to outcomes in the general population. SN - 1558-4410 UR - https://www.unboundmedicine.com/medline/citation/19217521/Lipid_management_in_chronic_kidney_disease_hemodialysis_and_transplantation_ DB - PRIME DP - Unbound Medicine ER -